Funding

Dr. Lerman's lab is supported by grants from the National Institutes of Health (NIH) and other extramural sources, which fund several research projects related to renal and cardiovascular physiology and pathophysiology. Dr. Lerman also mentors other principal investigators on their NIH-funded research projects.

Investigator & Role Grant Title Funding Source Duration
Lilach O. Lerman, M.D., Ph.D., principal investigator Quantitative magnetization transfer MRI for evaluation of renal fibrosis NIH, R01DK122734 03/15/2020-01/31/2024
Lilach O. Lerman, M.D., Ph.D., principal investigator Obesity-induced mesenchymal stem cell senescence NIH, R01 DK120292 12/27/2018-11/30/2022
Lilach O. Lerman, M.D., Ph.D., principal investigator Noninvasive evaluation of renal allograft fibrosis by MRI NIH, R21AG 62104 06/15/2020-03/31/2022
Xiangyang Zhu, M.D., Ph.D., principal investigator; Lilach O. Lerman, M.D., Ph.D., mentor Delivery of VEGF mRNA in a porcine model of renal artery stenosis Astra Zeneca Pharmaceuticals 07/17/2020-07/16/2022
Sabena M. Conley, Ph.D., principal investigator; Lilach O. Lerman, M.D., Ph.D., mentor Mesenchymal stem cell senescence in obesity Burroughs Wellcome Fund, 1018672 09/01/2018-08/31/2021
Sandra M. Herrmann, M.D., principal investigator; Lilach O. Lerman, M.D., Ph.D., mentor Hypoxic preconditioning for the improvement of the regenerative capacity of adipose-derived mesenchymal stem cells and its application in chronic kidney disease due to hypertensive nephropathy NIH, K08 DK118120-01 07/01/2018-05/31/2023
LaTonya J. Hickson, M.D., principal investigator; Lilach O. Lerman, M.D., Ph.D., mentor Mesenchymal stem cell senescence in diabetic nephropathy NIH, K23DK109134 07/01/2016-04/30/2021